Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of signing consent
- People who have a heart rhythm problem (affecting the upper or lower chambers of the heart) that has been recorded on a heart monitor test within the past 12 months, and for whom an ablation procedure is recommended based on established European heart rhythm guidelines
- People who can safely be near or exposed to magnetic fields
- People who are able and willing to attend follow-up visits at the study site for up to 12 months
- People who are willing and able to give their informed consent to participate
Who may not be able to join:
- People who have an implanted device that is not safe around magnetic fields, or a device that cannot be safely removed before the procedure
- People who are unable to lie flat on their back comfortably or without their blood pressure becoming unstable for an extended period of time
- People who weigh more than 200 kg (the maximum weight the procedure table can support)
- Women of childbearing age who are pregnant, plan to become pregnant during the study, or who do not have a negative pregnancy test result
- People who have had a blood clot inside the heart within the past 12 weeks
- People where the study device (MAGiC) would need to pass across an artificial (prosthetic) heart valve
- Cases where the study device would be used in the coronary arteries (the blood vessels that supply the heart muscle)
- People with a known history of reactions or allergies to foreign objects, or who have severe allergies
- People who currently have an acute illness or an active infection anywhere in the body
- People with tissue or structural abnormalities that may increase the risk of complications after the procedure, including a reduced ability to fight infection
- People who cannot receive heparin (a blood-thinning medication) or a suitable alternative to prevent blood clotting during the procedure
- People who have had a heart attack within the past 6 weeks
- People who have had heart surgery within the past 8 weeks
- People experiencing unstable chest pain (unstable angina) at the time of enrolment
- People who have had a stroke, mini-stroke (TIA), or a blood clot travelling to another part of the body within the past 30 days
- People who have had a previous heart ablation procedure within the past 30 days
- People who have had an electrical heart ablation procedure within the past 6 weeks
- People whose doctor estimates their life expectancy to be less than 12 months
- People who are currently participating, or who have participated within the past 30 days, in another interventional clinical trial
- People with significant uncontrolled or unstable health conditions that, in the investigator's opinion, would prevent them from completing the study
- People whom the investigator considers ineligible for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Betsy Lowry, Stereotaxis
Phone: 9737236613
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute Performance; Acute Safety
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.